The international medical humanitarian organization Médecins Sans Frontières (MSF) has expressed solidarity with the people living with HIV who are opposing the patent applications in India for two important HIV medicines, dolutegravir and cabotegravir. These patent oppositions have been filed to challenge an attempt by ViiV Healthcare (a joint venture by Pfizer and GlaxoSmithKline) to obtain monopoly rights in India while several of its patent claims are questionable according to Indian patentability criteria....In a statement, ViiV Healthcare spokesperson said, "We believe that our access to medicines strategy addresses the needs of people living with HIV in India. In 2013 we signed separate agreements with the Medicines Patent Pool (MPP) and Aurobindo to ensure access to our innovative antiretroviral medicines and combinations, including dolutegravir, where the need is greatest”.